Xi'an Xintong Pharmaceutical Research Co.,ltd.

This study tests a new tablet called hepenofovir fumarate (HTS) for people with chronic hepatitis B, a long-term liver infection. About 1,444 adults aged 18 to 65 who have not been treated before or have stopped treatment for at least 6 months will take either HTS or an existing …

This study tests a new drug called pracytarabine against the standard drug regorafenib in people with advanced liver cancer that has not responded to targeted therapy or immunotherapy. About 60 adults aged 18-75 with good liver function are taking part. The goal is to see if prac…